Clinical Trials Directory

Trials / Completed

CompletedNCT01962454

A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers

A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use With Dynamic Proteomic Measurement

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
Male
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

This is a single-blind, randomized placebo-controlled, parallel study, where the study volunteers will be blinded to testosterone/placebo treatment. This study will test a relatively new, less invasive method for collecting muscle tissue to determine if this method is appropriate for collecting muscle samples for the assessment of the fractional synthetic rates (FSR) of muscle-derived proteins. This study will also investigate whether the FSR of proteins may serve as early biomarkers for muscle anabolism, a known anabolic agent (testosterone) will be administered to healthy, elderly male subjects over a 3 week period. The fractional synthetic rate of several muscle-derived proteins will be analyzed at Baseline and during the period of testosterone treatment using deuterium labelling of these proteins by the incorporation of deuterium from deuterated water (D2O).

Conditions

Interventions

TypeNameDescription
DRUGDeuterated WaterD2O 70% will be supplied as clear liquid, provided in 50 millilitre (mL) unit dose vials; administered per orally.
DRUGTestosterone enanthateTestosterone enanthate 125mg injection will be supplied as colorless to pale yellow liquid; administered intramuscular (IM).
DRUGPlacebo to match testosterone enanthatePlacebo to match testosterone enanthate 0.625 mL injection will be supplied as greenish yellow, bright and clear oily liquid; administered intramuscular (IM).

Timeline

Start date
2014-05-05
Primary completion
2015-03-20
Completion
2015-03-20
First posted
2013-10-14
Last updated
2017-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01962454. Inclusion in this directory is not an endorsement.